Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases.

Sotgia F, Bonuccelli G, Minetti C, Woodman SE, Capozza F, Kemp RG, Scherer PE, Lisanti MP.

Am J Pathol. 2003 Dec;163(6):2619-34.

PMID:
14633633
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.

Smythe GM, Eby JC, Disatnik MH, Rando TA.

J Cell Sci. 2003 Dec 1;116(Pt 23):4739-49.

PMID:
14600260
[PubMed - indexed for MEDLINE]
Free Article
3.

Metabolic organization in vascular smooth muscle: distribution and localization of caveolin-1 and phosphofructokinase.

Vallejo J, Hardin CD.

Am J Physiol Cell Physiol. 2004 Jan;286(1):C43-54. Epub 2003 Aug 27.

PMID:
12944325
[PubMed - indexed for MEDLINE]
Free Article
4.

Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease.

Sotgia F, Woodman SE, Bonuccelli G, Capozza F, Minetti C, Scherer PE, Lisanti MP.

Am J Physiol Cell Physiol. 2003 Nov;285(5):C1150-60. Epub 2003 Jul 2.

PMID:
12839838
[PubMed - indexed for MEDLINE]
Free Article
5.
6.

Caveolin-1 functions as a scaffolding protein for phosphofructokinase in the metabolic organization of vascular smooth muscle.

Vallejo J, Hardin CD.

Biochemistry. 2004 Dec 28;43(51):16224-32.

PMID:
15610016
[PubMed - indexed for MEDLINE]
7.

Expression of the muscular dystrophy-associated caveolin-3(P104L) mutant in adult mouse skeletal muscle specifically alters the Ca(2+) channel function of the dihydropyridine receptor.

Weiss N, Couchoux H, Legrand C, Berthier C, Allard B, Jacquemond V.

Pflugers Arch. 2008 Nov;457(2):361-75. doi: 10.1007/s00424-008-0528-z. Epub 2008 May 29.

PMID:
18509671
[PubMed - indexed for MEDLINE]
8.

Expression of caveolin-1 in lymphocytes induces caveolae formation and recruitment of phosphofructokinase to the plasma membrane.

Vallejo J, Hardin CD.

FASEB J. 2005 Apr;19(6):586-7. Epub 2005 Jan 21.

PMID:
15665033
[PubMed - indexed for MEDLINE]
Free Article
9.

Caveolae and caveolin-3 in muscular dystrophy.

Galbiati F, Razani B, Lisanti MP.

Trends Mol Med. 2001 Oct;7(10):435-41. Review.

PMID:
11597517
[PubMed - indexed for MEDLINE]
10.

Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells.

Sotgia F, Razani B, Bonuccelli G, Schubert W, Battista M, Lee H, Capozza F, Schubert AL, Minetti C, Buckley JT, Lisanti MP.

Mol Cell Biol. 2002 Jun;22(11):3905-26.

PMID:
11997523
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.

Galbiati F, Volonte D, Minetti C, Chu JB, Lisanti MP.

J Biol Chem. 1999 Sep 3;274(36):25632-41.

PMID:
10464299
[PubMed - indexed for MEDLINE]
Free Article
12.

Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae.

Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou H Jr, Christ GJ, Edelmann W, Lisanti MP.

Mol Cell Biol. 2002 Apr;22(7):2329-44.

PMID:
11884617
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.

Hnasko R, Lisanti MP.

Mol Interv. 2003 Dec;3(8):445-64. Review.

PMID:
14993453
[PubMed - indexed for MEDLINE]
14.

Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.

Volonte D, Peoples AJ, Galbiati F.

Mol Biol Cell. 2003 Oct;14(10):4075-88. Epub 2003 Aug 7.

PMID:
14517320
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

cav-p60 expression in rat muscle tissues. Distribution of caveolar proteins.

Voldstedlund M, Vinten J, Tranum-Jensen J.

Cell Tissue Res. 2001 Nov;306(2):265-76.

PMID:
11702238
[PubMed - indexed for MEDLINE]
16.

Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.

Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP.

J Biol Chem. 2001 Oct 12;276(41):38121-38. Epub 2001 Jul 16.

PMID:
11457855
[PubMed - indexed for MEDLINE]
Free Article
17.
18.

Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.

Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, Shirani J, Razani B, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP.

Am J Pathol. 2002 Jun;160(6):2207-17.

PMID:
12057923
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro.

Traverso M, Gazzerro E, Assereto S, Sotgia F, Biancheri R, Stringara S, Giberti L, Pedemonte M, Wang X, Scapolan S, Pasquini E, Donati MA, Zara F, Lisanti MP, Bruno C, Minetti C.

Lab Invest. 2008 Mar;88(3):275-83. doi: 10.1038/labinvest.3700713. Epub 2008 Feb 4.

PMID:
18253147
[PubMed - indexed for MEDLINE]
Free Article
20.

A CAV3 microdeletion differentially affects skeletal muscle and myocardium.

Cagliani R, Bresolin N, Prelle A, Gallanti A, Fortunato F, Sironi M, Ciscato P, Fagiolari G, Bonato S, Galbiati S, Corti S, Lamperti C, Moggio M, Comi GP.

Neurology. 2003 Dec 9;61(11):1513-9.

PMID:
14663034
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk